These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7603097)

  • 1. [Therapeutic immunoadsorption in Goodpasture disease].
    Moreso F; Poveda R; Gil-Vernet S; Carreras L; García-Osuna R; Griñó JM; Alsina J
    Med Clin (Barc); 1995 Jun; 105(2):59-61. PubMed ID: 7603097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.
    Hu W; Liu Z; Ji D; Xie H; Gong D; Li L
    J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of kidney-bound antibodies in Goodpasture's syndrome.
    Saxena R; Bygren P; Butkowski R; Wieslander J
    Clin Exp Immunol; 1989 Oct; 78(1):31-6. PubMed ID: 2805421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption in Goodpasture's syndrome.
    Laczika K; Knapp S; Derfler K; Soleiman A; Hörl WH; Druml W
    Am J Kidney Dis; 2000 Aug; 36(2):392-5. PubMed ID: 10922318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
    Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation, immunosuppression and plasmapheresis in Goodpasture's syndrome.
    Cove-Smith JR; McLeod AA; Blamey RW; Knapp MS; Reeves WG; Wilson CB
    Clin Nephrol; 1978 Mar; 9(3):126-8. PubMed ID: 346273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Goodpasture's syndrome--effects of plasmapheresis.
    Munk ZM; Skamene E
    Clin Exp Immunol; 1979 May; 36(2):244-9. PubMed ID: 477027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-GBM disease: predictive value of clinical, histological and serological data.
    Herody M; Bobrie G; Gouarin C; Grünfeld JP; Noel LH
    Clin Nephrol; 1993 Nov; 40(5):249-55. PubMed ID: 8281713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Double filtration plasmapheresis in case of Goodpasture's syndrome].
    Kumazaki S; Umeda Y; Sato K; Mishima H; Ishihara T; Uzawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):628-33. PubMed ID: 2214405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goodpasture's syndrome with asymptomatic renal involvement. Disappearance of antiglomerular basement membrane antibodies deposits after treatment.
    Lamriben L; Kourilsky O; Mougenot B; Ronco P; Sraer JD
    Nephrol Dial Transplant; 1993; 8(11):1267-9. PubMed ID: 8302468
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics and outcomes of patients with Goodpasture's syndrome.
    Shah MK; Hugghins SY
    South Med J; 2002 Dec; 95(12):1411-8. PubMed ID: 12597309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Goodpasture's syndrome].
    Shinjo SK; Hasegawa EM; Costa Malheiros DM; Levy-Neto M
    Acta Reumatol Port; 2008; 33(2):220-3. PubMed ID: 18604188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome.
    Erickson SB; Kurtz SB; Donadio JV; Holley KE; Wilson CB; Pineda AA
    Mayo Clin Proc; 1979 Nov; 54(11):714-20. PubMed ID: 491763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture's syndrome.
    Johnson JP; Whitman W; Briggs WA; Wilson CB
    Am J Med; 1978 Feb; 64(2):354-9. PubMed ID: 629280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
    Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases.
    Merkel F; Pullig O; Marx M; Netzer KO; Weber M
    Nephrol Dial Transplant; 1994; 9(4):372-6. PubMed ID: 8084449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of anti-basement membrane (BM) mediated disease presenting renal and pulmonary symptoms by divergent timing].
    Usutani S; Nosaka H; Shirai M; Akimoto H; Kojima K; Shimomura M; Kakuta S; Nagase M; Sado Y
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):512-6. PubMed ID: 9283218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.